Losartan interactions with vitamins
Pro Research Analysisby 
Searched over 200M research papers
Losartan Interactions with Vitamins
Introduction to Losartan and Vitamin Interactions
Losartan, an angiotensin II receptor antagonist, is commonly prescribed for hypertension and certain kidney conditions. Recent studies have explored its interactions with various vitamins, particularly focusing on potential synergistic or antagonistic effects. This article synthesizes findings from multiple research papers to provide a comprehensive overview of how losartan interacts with vitamins E, D, and others.
Losartan and Vitamin E: Nephrotoxicity and Renal Protection
Protective Effects Against Nephrotoxicity
Research has investigated the combined effects of losartan and vitamin E in protecting against cisplatin-induced nephrotoxicity. In a study involving Wistar rats, both losartan and vitamin E showed some protective effects individually. However, their combination did not offer additional protection, suggesting possible pharmacokinetic or pharmacodynamic interactions that negate their combined efficacy .
Renal Injury from Extracorporeal Shockwave Lithotripsy
Another study evaluated the renal protective effects of selenium combined with vitamins A, C, and E, alongside losartan and verapamil, against renal injury induced by extracorporeal shockwave lithotripsy (ESWL). This study aimed to determine if these combinations could mitigate renal damage, although specific outcomes regarding losartan and vitamin interactions were not detailed .
Losartan and Vitamin D: Cardiovascular and Anti-Inflammatory Benefits
Myocardial Ischemia-Reperfusion Injury
The co-administration of losartan and 1,25-dihydroxyvitamin D has been shown to reduce myocardial infarct size and reperfusion-induced arrhythmia in rats. This combination also increased the transcription of prosurvival factors, indicating a synergistic protective effect on the heart .
Rheumatoid Arthritis
In a study on rheumatoid arthritis induced by complete Freund's adjuvant, both vitamin D and losartan significantly reduced inflammatory markers and improved hematological parameters. This suggests that both agents can effectively mitigate the inflammatory and oxidative stress associated with arthritis .
Cardiac Hypertrophy
Vitamin D analogs, when combined with losartan, have demonstrated significant antihypertrophic effects in spontaneously hypertensive rats. The combination therapy not only reduced left ventricular hypertrophy but also normalized renin expression, which is typically elevated with losartan monotherapy. This indicates a potent synergistic effect in managing cardiac hypertrophy .
Conclusion
The interactions between losartan and vitamins, particularly E and D, reveal a complex interplay that can either enhance or negate therapeutic effects depending on the context. While vitamin E and losartan individually offer renal protection, their combination does not provide additional benefits against nephrotoxicity. Conversely, vitamin D combined with losartan shows promising synergistic effects in reducing myocardial infarct size, managing rheumatoid arthritis, and preventing cardiac hypertrophy. These findings underscore the importance of understanding drug-vitamin interactions to optimize therapeutic outcomes.
Sources and full results
Most relevant research papers on this topic